MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2022 International Congress

    Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up

    T. Fedorova, K. Knudsen, K. Andersen, J. Horsager, C. Skjærbæk, M. Otto, K. Svendsen, P. Borghammer (Aarhus N, Denmark)

    Objective: To image progression of intestinal dysfunction, cardiac sympathetic denervation, and dopaminergic nigrostriatal damage in patients with isolated REM sleep behaviour disorder (iRBD). Background: A…
  • 2022 International Congress

    Visualising cholinergic nerves in dementia with Lewy bodies using PET and FEOBV

    N. Okkels, J. Horsager, A. Hansen, M. Damholdt, P. Kjeldsen, K. Vestergaard, K. Andersen, C. Skjærbæk, T. Fedorova, J. Mortensen, G. Bekan, H. Gottrup, P. Borghammer (Aarhus N, Denmark)

    Objective: Investigate the cholinergic integrity of the central nervous system in dementia with Lewy bodies using PET and a tracer for the vesicular acetylcholine transporter.…
  • 2022 International Congress

    [18F]FDG PET in hyperkinetic movement disorders: a systematic review

    E. Timmers, M. Klamer, R. Marapin, A. Lammertsma, B. de Jong, R. Dierckx, M. Tijssen (Groningen, Netherlands)

    Objective: To give a comprehensive literature overview of alterations in regional cerebral glucose metabolism, measured using [18F]FDG PET, in hyperkinetic movement disorders. In addition, correlations…
  • 2022 International Congress

    Does autosomal recessive Parkinson’s Disease behave as “Brain-first” subtype?

    B. Soydas-Turan, G. Yalcin-Cakmakli, B. Volkan-Salanci, E. Lay-Ergun, B. Elibol (Ankara, Turkey)

    Objective: The aim of this study is to explore whether monogenic PD (due to parkin or DJ-1 homozygous mutations) can be subtyped as "brain-first" by…
  • 2022 International Congress

    Muscarinic M2 cholinergic receptors in cervical dystonia

    P. Kassavetis, M. Hosseini, K. Mente, R. Waugh, E. Shamim, W. Dieckmann, P. Herscovitch, M. Hallett, S. Horovitz (Salt Lake City, USA)

    Objective: To characterize the M2 muscarinic acetylcholine receptor binding in patients with cervical dystonia, measured with non-invasive high-resolution PET, using [18F]FP-TZTP ligand. Background: While antimuscarinic…
  • 2022 International Congress

    Retinal thickness as a marker of disease progression in progressive supranuclear palsy

    Y. Chen, H. Wang, B. Wang, B. Li, P. Ye, W. Xu, P. Liu, X. Chen, Z. Cen, Z. Ouyang, S. Wu, X. Dou, Y. Liao, W. Luo (Hangzhou, China)

    Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…
  • 2022 International Congress

    White matter structural network of motor reserve in early Parkinson’s disease

    S. Chung, Y. Kim, C. Park, H. Shin, H. Lee, Y. Kim, M. Yun, P. Lee, Y. Sohn, Y. Jeong (Yongin-si, Republic of Korea)

    Objective: This study aims to explore the white matter structural network associated with motor reserve (i.e., individual capacity to cope with nigrostriatal dopamine depletion) in…
  • MDS Virtual Congress 2021

    Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study

    K. Steidel, M. Ruppert, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, D. Pedrosa, C. Eggers (Marburg, Germany)

    Objective: To investigate the longitudinal course of nigrostriatal metabolic and dopaminergic dysfunction and its impact on symptom severity in Parkinson's disease (PD) patients using a…
  • MDS Virtual Congress 2021

    Cognitive-affective syndrome related to cerebellar hypometabolism secondary to Covid-19 infection : a case report

    S. Potel, M. Merceur, P. Méneret, S. Butet, P. Guillemot, G. Silvestre-Beccarel, I. Bonan, F. Le Jeune, M. Vérin (Rennes, France)

    Objective: To describe a novel case of Covid-19-related cognitive affective syndrome with cerebellar hypometabolism and associated neuropathy. Background: Several Covid-19-related neurological diseases have been described, including…
  • MDS Virtual Congress 2021

    VMAT2 availability in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

    M. Valli, SS. Cho, C. Uribe, M. Masellis, R. Chen, A. Mihaescu, A. Strafella (Toronto, Canada)

    Objective: To use [11C]DTBZ PET imaging to explore vesicular monoamine transporter 2 (VMAT2) availability in Parkinson’s disease (PD) with and without rapid eye movement sleep…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley